Literature DB >> 19967320

Multifocal epithelioid glioblastoma mimicking cerebral metastasis: case report.

J Gasco1, B Franklin, G N Fuller, P Salinas, S Prabhu.   

Abstract

OBJECTIVE: Epithelioid glioblastoma is a rare morphologic subtype of glioblastoma that closely mimics metastatic carcinoma or metastatic melanoma histologically. All previous case reports of this unusual glioblastoma variant have been solitary lesions. We report here the first case to our knowledge of multifocal epithelioid glioblastoma mimicking cerebral metastasis. CLINICAL
PRESENTATION: A 67-year-old man with a prior history of mycosis fungoides, a common form of cutaneous T-cell lymphoma, presented with memory loss and impaired peripheral vision. Two discrete brain lesions highly suspicious for metastases were identified by magnetic resonance imaging (MRI). INTERVENTION: The patient underwent two separate craniotomies; both lesions were successfully resected in toto with an excellent post-surgical outcome.
CONCLUSION: Epithelioid glioblastoma is one of the rarest morphologic subtypes of glioblastoma. Here we describe the first case to our knowledge of multifocal epithelioid glioblastoma that convincingly mimicked a secondary metastatic process. Multifocal epithelioid glioblastoma should be included in the differential diagnosis of patients who present with multiple discrete brain lesions. An attempt at gross total resection is recommended when anatomically feasible for definitive histopathological diagnosis and to improve progression free survival of patients who present with similarly ambiguous and potentially misleading multiple lesions.

Entities:  

Mesh:

Year:  2009        PMID: 19967320     DOI: 10.1016/s1130-1473(09)70133-2

Source DB:  PubMed          Journal:  Neurocirugia (Astur)        ISSN: 1130-1473            Impact factor:   0.553


  8 in total

1.  BRAF VE1 immunoreactivity patterns in epithelioid glioblastomas positive for BRAF V600E mutation.

Authors:  Bette K Kleinschmidt-DeMasters; Dara L Aisner; Nicholas K Foreman
Journal:  Am J Surg Pathol       Date:  2015-04       Impact factor: 6.394

2.  Clinicopathological characteristics and treatment outcomes of epithelioid glioblastoma.

Authors:  Kaijun Sun; Xingwang Zhou; Tengfei Li; Mingrong Zuo; Junhong Li; Yanhui Liu
Journal:  Neurosurg Rev       Date:  2021-02-17       Impact factor: 3.042

3.  Epithelioid GBMs show a high percentage of BRAF V600E mutation.

Authors:  Bette Kay Kleinschmidt-DeMasters; Dara L Aisner; Diane K Birks; Nicholas K Foreman
Journal:  Am J Surg Pathol       Date:  2013-05       Impact factor: 6.394

Review 4.  Central Nervous System Involvement of Natural Killer and T Cell Neoplasms.

Authors:  Ashley E Aaroe; Kathryn S Nevel
Journal:  Curr Oncol Rep       Date:  2019-03-27       Impact factor: 5.945

5.  Clinicopathological, Immunohistochemical and Molecular Genetic Study on Epithelioid Glioblastoma: A Series of Fifteen Cases with Literature Review.

Authors:  Ying Zeng; Xiangfeng Zhu; Yali Wang; Bo Liu; Xin Yang; Qiushi Wang; Juan Du; Yu Ma; Li Lin; Ping Fu; Hualiang Xiao; Qiao-Nan Guo
Journal:  Onco Targets Ther       Date:  2020-05-08       Impact factor: 4.147

6.  Composite pleomorphic xanthoastrocytoma-epithelioid glioneuronal tumor with BRAF V600E mutation - report of three cases.

Authors:  Dara L Aisner; Kathy L Newell; Ania G Pollack; Bette K Kleinschmidt-Demasters; Gary K Steinberg; Lawrence T Smyth; Hannes Vogel
Journal:  Clin Neuropathol       Date:  2014 Mar-Apr       Impact factor: 1.368

7.  BRAF V600E mutation and BRAF VE1 immunoexpression profiles in different types of glioblastoma.

Authors:  Zeynep Tosuner; Melin Özgün Geçer; Mustafa Aziz Hatiboğlu; Anas Abdallah; Seval Turna
Journal:  Oncol Lett       Date:  2018-06-06       Impact factor: 2.967

8.  Multimodal MR Features of 8 Cases of Epithelioid Glioblastoma.

Authors:  Ji-Ping Zhao; Chun-Xiao Cui; Jia-Chen Wang; Hua-Wei Su; Chong-Feng Duan; Xue-Jun Liu
Journal:  Biomed Res Int       Date:  2020-10-16       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.